Diabetes: Global treatment gap is widening, study finds
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj.q2515 (Published 14 November 2024) Cite this as: BMJ 2024;387:q2515- Gareth Iacobucci
- The BMJ
More than 800 million adults around the world now have type 1 or type 2 diabetes, a global analysis has estimated—more than four times the number in 1990.
Almost six in 10 adults aged over 30 with diabetes, equal to around 445 million people, did not receive treatment in 2022, three and a half times as many as in 1990, research in the Lancet found.1 The study found that while treatment rates had improved in many high income and industrialised nations and some emerging economies, treatment had stagnated at low levels in many low income countries where diabetes has drastically increased.
Majid Ezzati, senior author and a professor of global environmental health at Imperial College London, said that the results highlighted “widening global inequalities” in diabetes treatment. “This is especially concerning as people with diabetes tend to be younger in low income …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.